Current Opinion in Hematology was launched in 1994. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of hematology is divided into nine sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editor for this issue.
Martin S. Tallman
Martin S. Tallman, is Professor of Medicine at the Northwestern University Feinberg School of Medicine and Co-Director of the Hematologic Malignancy Program at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University in Chicago, Illinois. He is a diplomate of the American Board of Internal Medicine with subspecialty certification in the areas of hematology and medical oncology. He serves as Chair of the Leukemia Committee of the Eastern Cooperative Oncology Group.
Dr. Tallman received his bachelor's degree in science at the University of Michigan in Ann Arbor, Michigan, and his medical degree at Finch University of Health Sciences/The Chicago Medical School in Chicago, Illinois. After completing an internship, residencies, and chief residency at McGaw Medical Center at Northwestern University, Dr. Tallman completed his fellowship in hematology/oncology at the University of Washington and the Fred Hutchinson Cancer Research Center in Seattle, Washington. Over the years, Dr. Tallman has received several awards for his outstanding contributions to the field, including the John T. O'Connell Award of the Chicago Medical Society, for his work on treatment for hairy cell leukemia and other lymphoproliferative disorders, and the Woman's Board Compassionate Care Award from Northwestern Memorial Hospital.
Dr. Tallman is a member of numerous committees of national, regional, and international professional societies involved in the study and treatment of cancer, including the American Society of Hematology, American Society of Clinical Oncology, the Eastern Cooperative Oncology Group, the International Society of Thrombosis and Haemostasis, and the American Association for Cancer Research. He serves on the Acute Myeloid Leukemia, Chronic Myeloid Leukemia and Myelodysplastic Syndrome Committees of the National Comprehensive Cancer Network (NCCN). He is a fellow of the American College of Physicians.
Dr. Tallman has contributed a large body of work to the literature addressing the diagnosis, biology, and treatment of acute leukemia and other hematologic malignancies. This work includes original research articles in peer-reviewed journals, textbook chapters and reviews, monographs, editorials, and abstracts. He has spoken as an invited lecturer and chair at many national and international symposia, conferences, and meetings, including the American Society of Hematology Meeting, the American Society of Clinical Oncology Meeting, the IBMTR/ABMTR Annual Meeting, NCCN Annual Meeting, and the Third Annual Oncology Fellows Forum.
Dr. Tallman serves as an Associate Editor of Blood. He is a reviewer for many professional publications, including American Journal of Hematology, Annals of Internal Medicine, Bone Marrow Transplantation, Cancer Research, Journal of Clinical Oncology, and New England Journal of Medicine. He also serves on the editorial boards of a variety of scientific journals, including Leukemia, Leukemia Research, Cancer, Clinical Cytometry, Evidence-Based Oncology, Blood Reviews, Annals of Hematology, and the Hematology Journal.